Empiric Antibiotics Regimens for Common Infections
Empiric Antibiotics Regimens for Common Infections
Infection
|
Common
Pathogens
|
Patient/Infection Factors
|
Initial Empiric Therapy
Options
|
Community acquired pneumonia
|
Streptococcus pneumoniae
Haemophilus influenzae
Mycoplasma pneumoniae Chlamydophila
pneumoniae
Legionella pneumophila
|
Outpatient, otherwise healthy, no recent antibiotic exposure
|
Doxycycline or Azithromycin
or Clarithromycin
|
Outpatient, comorbidities and/or recent antibiotic
exposure
|
Amoxicillin or
Amoxicillin/Clavulanate or
Cefuroxime
-Plus-
Azithromycin or
Clarithromycin
-OR-
Levofloxacin or Moxifloxacin
or Gemifloxacin
|
||
Inpatient, non-ICU
|
Ceftriaxone or Cefotaxime or
Ampicillin or Ertapenem
-Plus-
Azithromycin or
Clarithromycin or Doxycycline
-OR-
Levofloxacin or Moxifloxacin
|
||
Inpatient, ICU
|
Ceftriaxone or Cefotaxime or
Ampicillin/Sulbactam
-Plus-
Azithromycin or Levofloxacin
or Moxifloxacin
|
Healthcare associated
pneumonia
|
Streptococcus pneumoniae
Haemophilus influenzae Staphylococcus aureus (MSSA)
Escherichia coli Klebsiella
pnueumoniae
|
Early-onset (within 5 days of hospitalization) and no recent antibiotic exposure
|
Ceftriaxone or
Ampicillin/Sulbactam or
Ertapenem or Levofloxacin or
Moxifloxacin
|
As above plus: Staphylococcus
aureus (MRSA) Enterobacter species Proteus
species Serratia species
Pseudomonas aeruginosa
|
Late-onset (after 5 days of hospitalization) and/or recent
antibiotic exposure
|
Cefepime or Ceftazidime or
Imipenem or Meropenem or
Piperacillin/Tazobactam or
Aztreonam
-Plus-
Ciprofloxacin or Levofloxacin
or Gentamicin or Tobramycin
or Amikacin
-Plus-
Vancomycin or Linezolid
|
|
Otitis media
|
Viruses Streptococcus pneumoniae Haemophilus
influenzae Moraxaella catarrhalis
|
Mild-moderate otalgia with
temperature ≤ 39°C
|
Amoxicillin or Cefuroxime or
Cefpodoxime or Azithromycin
|
Severe otalgia and/or
temperature ≥ 39°C
|
Amoxicillin/Clavulanate or
Ceftriaxone
|
||
Pharyngitis
|
Viruses Streptococcus pyogenes
|
Documented or high risk for
Streptococcus pyogenes
|
Penicillin VK or Cephalexin or
Azithromycin
|
Urinary tract infections
|
Escherichia coli
Proteus species Klebsiella
pneumoniae
Staphylococcus
|
Uncomplicated communityacquired lower urinary tract
infection in healthy women, <
50 years old
|
TMP/SMX or Nitrofurantoin or
Fosfomycin or
Ciprofloxacin or Levofloxacin
|
saphrophyticus Enterococcus species
|
|||
Community-acquired complicated urinary tract
infection or pyelonephritis
|
Ciprofloxacin or Levofloxacin
or Ceftriaxone or Ertapenem
|
||
As above plus: Enterobacter
species
Pseudomonas aeruginosa
|
Nosocomial complicated urinary tract infection or pyelonephritis
|
Ceftazidime or
Piperacillin/Tazobactam or
Cefepime or Meropenem or
Imipenem
|
|
Skin/soft
tissue infections
|
Streptococcus pyogenes
Staphylococcus aureus
|
Low risk for MRSA
|
Cefazolin or Nafcillin or
Cephalexin or Dicloxacillin
|
High risk for MRSA
|
Vancomycin or Linezolid or
Clindamycin
-OR-
Cephalexin or Dicloxacillin
-Plus-
Doxycycline or TMP/SMX
|
||
As above plus:
Escherichia coli
Proteus species Klebsiella
pneumoniae Bacteroides
fragilis
Enterococcus species
Pseudomonas aeruginosa
|
Diabetic foot infection,
moderate to severe
|
Ceftriaxone or
Ampicillin/Sulbactam or
Piperacillin/Tazobactam or
Ertapenem
-OR-
Levofloxacin or Ciprofloxacin
-Plus-
Clindamycin
All WITH or WITHOUT
Vancomycin
|
|
Intra-
abdominal
infections
|
Escherichia coli
Proteus species
Klebsiella
|
Community-acquired, mildmoderate severity
|
Ertapenem or Moxifloxacin or
Tigecycline
-OR-
Cefazolin or Ceftriaxone or
|
pneumoniae Bacteroides fragilis
Enterococcus species
viridans
Streptococcus
|
Levofloxacin or Ciprofloxacin
-Plus-
Metronidazole
|
||
As above plus:
Pseudomonas aeruginosa Enterobacter
spp
Serratia spp
|
Community-acquired, high severity or high-risk patient
-OR-
Nosocomial (any severity or patient)
|
Piperacillin/Tazobactam or
Imipenem or Meropenem
-OR-
Ceftazidime or Cefepime
-Plus-
Metronidazole
All WITH or WITHOUT
Vancomycin
|
|
Community acquired
meningitis
|
Streptococcus pneumoniae Neisseria
meningitidis
|
Otherwise healthy, 2–50 years of age
|
Ceftriaxone
-Plus-
Vancomycin
|
As above plus: Listeria
monocytogenes
|
> 50 years of age or
immunocompromised
|
Ceftriaxone
-Plus-
Vancomycin
-PlusAmpicillin
|
|
Healthcare associated
infectious diarrhea
|
Clostridium
difficile
|
Mild-moderate infection
|
Metronidazole (oral)
|
Severe infection
|
Vancomycin (oral) or
Fidaxomicin
|
||
Severe, complicated infection
(e.g., ileus)
|
Vancomycin (oral)
-Plus-
Intravenous metronidazole
|
||
Community acquired
infectious
|
Shigella
Salmonella
Escherichia coli
|
See above
|
Fluoroquinolone or TMP/SMX
if antibiotic therapy is
necessary
|
diarrhea
|
Campylobacter Clostridium
difficile
(uncommon)
|